⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10409103 | 1.00 | — | — | |
| SCHEMBL9700025 | 0.83 | — | — | |
| SCHEMBL20595689 | 0.79 | — | — | |
| SCHEMBL9300886 | 0.78 | — | — | |
| SCHEMBL5167517 | 0.77 | — | — | |
| SCHEMBL6932758 | 0.73 | — | — | |
| SCHEMBL10869219 | 0.73 | — | — | |
| SCHEMBL9580881 | 0.73 | — | — | |
| SCHEMBL9152933 | 0.73 | — | — | |
| SCHEMBL9505385 | 0.72 | MAPT (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3281941-B1 | PROCESS FOR PREPARING 2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID | ZENTIVA KS (CZ) | 2019-07-24 | — | — | EP | claimed |
| EP-3281941-A1 | PROCESS FOR PREPARING 2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID | Zentiva K.S. (CZ) | 2018-02-14 | — | — | EP | claimed |
| WO-2026099466-A1 | TARGETED PROTEIN DEGRADATION | MONTE ROSA THERAPEUTICS AG (CH) | 2026-05-15 | — | — | WO | disclosed |
| EP-4384165-A1 | MONOACYLGLYCEROL LIPASE MODULATORS FOR USE IN AUTISM SPECTRUM DISORDERS | Janssen Pharmaceutica NV (BE) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023019094-A1 | MONOACYLGLYCEROL LIPASE MODULATORS FOR USE IN AUTISM SPECTRUM DISORDERS | JANSSEN PHARMACEUTICA NV (BE) | 2023-02-16 | — | — | WO | disclosed |
| EP-4103557-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | Janssen Pharmaceutica NV (BE) | 2022-12-21 | — | — | EP | disclosed |
| EP-3890738-A1 | MACROCYCLIC COMPOUND AND USE THEREOF | Scohia Pharma, Inc. (JP) | 2021-10-13 | — | — | EP | disclosed |
| WO-2021160602-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-08-19 | — | — | WO | disclosed |
| WO-2020116660-A1 | MACROCYCLIC COMPOUND AND USE THEREOF | SCOHIA PHARMA, INC. (JP) | 2020-06-11 | — | — | WO | disclosed |
| EP-3624797-A1 | KINASE INHIBITORS AND USES THEREOF | Denali Therapeutics Inc. (US) | 2020-03-25 | — | — | EP | disclosed |
| EP-3281941-B1 | PROCESS FOR PREPARING 2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID | ZENTIVA KS (CZ) | 2019-07-24 | — | — | EP | disclosed |
| WO-1992007013-A1 | NOVEL SILICONE-CONTAINING POLYMERS AND OXYGEN PERMEABLE HYDROPHILIC CONTACT LENSES THEREFROM | PERMEABLE TECHNOLOGIES, INC. (US) | 1992-04-30 | — | — | WO | disclosed |
| WO-1992007014-A1 | NOVEL SILICONE-CONTAINING ACRYLIC STAR POLYMERS, BLOCK COPOLYMERS AND MACROMONOMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-30 | — | — | WO | disclosed |
| EP-0457765-A4 | POSITIVE SOLID BLOCK TONER | — | 1992-01-22 | — | — | EP | disclosed |
| EP-0457765-A1 | POSITIVE SOLID BLOCK TONER. | DU PONT (US) | 1991-11-27 | — | — | EP | disclosed |
| WO-1990007257-A2 | POSITIVE SOLID BLOCK TONER | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-07-12 | — | — | WO | disclosed |
| US-4925764-A | CHARGE CONTROL AGENTS | E. I. DU PONT DE NEMOURS & CO. (US) | 1990-05-15 | — | — | US | disclosed |
| EP-0243120-A2 | Tough flexible polymer blends | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-10-28 | — | — | EP | disclosed |
| EP-0121439-A1 | Tris(dialkylamino)sulfonium bifluoride catalysts | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-10-10 | — | — | EP | disclosed |
| EP-0068887-A1 | \"Living\" polymers and process for their preparation | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-01-05 | — | — | EP | disclosed |